Honoka Arai

Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.

Kenji Saito, Y Nakamura, Mitsuo Aoyagi et al. · PubMed · 2000 · 72 citations

Medicine, Hematology, Pharmacology +17

Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation

Kazuhiro Maki, Honoka Arai, Kazuo Waga et al. · Molecular and Cellular Biology · 2004 · 41 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Functional regulation of TEL by p38-induced phosphorylation

Honoka Arai, Kazuhiro Maki, Kazuo Waga et al. · Biochemical and Biophysical Research Communications · 2002 · 34 citations

Life Sciences, Cell Biology, Molecular Biology +7

Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells

Kazuo Waga, Yuichi Nakamura, Kazuhiro Maki et al. · Oncogene · 2003 · 24 citations

Life Sciences, Genetics, Molecular Biology +7

Functional analysis of a dominant-negative ΔETS TEL/ETV6 isoform

Ko Sasaki, Yuka Nakamura, Kazuhiro Maki et al. · Biochemical and Biophysical Research Communications · 2004 · 21 citations

Life Sciences, Molecular Biology, Molecular Genetics +2